Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic

Am J Hypertens. 2023 Jun 15;36(7):360-362. doi: 10.1093/ajh/hpad031.
No abstract available

Keywords: 2; ACE2; COVID-19 pandemic; SARS-COV; blood pressure; cardiovascular disease; hypertension; renin-angiotensin system inhibitors.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antihypertensive Agents / pharmacology
  • COVID-19*
  • Humans
  • Pandemics
  • Peptidyl-Dipeptidase A / metabolism
  • Renin-Angiotensin System / drug effects
  • SARS-CoV-2

Substances

  • Peptidyl-Dipeptidase A
  • Antihypertensive Agents